These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 32388409)
1. A potential protective effect of metformin in adenoid cystic carcinoma. Lancione PJ; Kumar B; Zhao S; Mroz EA; Brock G; Rocco JW; Carrau RL; Agrawal A; Seim N; Kang SY; Ozer E; Old MO Oral Oncol; 2020 Aug; 107():104726. PubMed ID: 32388409 [No Abstract] [Full Text] [Related]
2. Metformin: fifty-two not out. Campbell IW J Indian Med Assoc; 2009 Nov; 107(11):779-84. PubMed ID: 20469782 [No Abstract] [Full Text] [Related]
3. Metformin: a review of its potential indications. Wang YW; He SJ; Feng X; Cheng J; Luo YT; Tian L; Huang Q Drug Des Devel Ther; 2017; 11():2421-2429. PubMed ID: 28860713 [TBL] [Abstract][Full Text] [Related]
4. Metformin and the Gut Microbiome in Diabetes. Devaraj S; Venkatachalam A; Chen X Clin Chem; 2016 Dec; 62(12):1554-1555. PubMed ID: 27650682 [No Abstract] [Full Text] [Related]
8. Metformin in polycystic ovary syndrome. Fisken RA N Engl J Med; 2008 Apr; 358(17):1866-7; author reply 1868. PubMed ID: 18437727 [No Abstract] [Full Text] [Related]
9. The expression of MACC1 and its role in the proliferation and apoptosis of salivary adenoid cystic carcinoma. Li H; Liao X; Liu Y; Shen Z; Gan X; Li H; Huang Z J Oral Pathol Med; 2015 Nov; 44(10):810-7. PubMed ID: 25640194 [TBL] [Abstract][Full Text] [Related]
10. Metformin: an advance in ovulation induction. Turner MJ; Langan H; Farah N; Byrne K; Cleary B Ir Med J; 2005 May; 98(5):133-4. PubMed ID: 16010777 [No Abstract] [Full Text] [Related]
12. [Metformin and type-2 diabetes mellitus]. Mata Cases M Aten Primaria; 2008 Mar; 40(3):147-53. PubMed ID: 18373928 [No Abstract] [Full Text] [Related]
13. Association between pancreatic cancer and metformin use in patients with type 2 diabetes. Lai SW; Tsai CH; Lin CL; Liao KF Postgrad Med J; 2019 May; 95(1123):291. PubMed ID: 30975725 [No Abstract] [Full Text] [Related]
17. In brief: New recommendations for use of metformin in renal impairment. Med Lett Drugs Ther; 2016 Apr; 58(1493):51. PubMed ID: 27101208 [No Abstract] [Full Text] [Related]
18. Mechanisms involved in the protective effects of metformin against nonalcoholic fatty liver disease. Barbero-Becerra VJ; Santiago-Hernandez JJ; Villegas-Lopez FA; Mendez-Sanchez N; Uribe M; Chavez-Tapia NC Curr Med Chem; 2012; 19(18):2918-23. PubMed ID: 22519397 [TBL] [Abstract][Full Text] [Related]
19. Role of metformin in type II diabetes. Epstein S Cleve Clin J Med; 1995; 62(5):278-9. PubMed ID: 7586481 [No Abstract] [Full Text] [Related]
20. Summaries for patients. Metformin for patients with type 2 diabetes mellitus. Ann Intern Med; 2002 Jul; 137(1):I50. PubMed ID: 12093266 [No Abstract] [Full Text] [Related] [Next] [New Search]